CoChat

Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials

Zhang, Xiao-Wen, Zhang, Xin-Lin, Xu, Biao, Kang, Li-Na · 2018 · Acta Diabetologica

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Aims To determine the safety and efficacy of insulin degludec versus glargine in patients with type 1 (T1D) and type 2 (T2D) diabetes mellitus. Methods Databases were searched until July 5, 2017. We included randomized controlled trials comparing degludec with glargine in diabetic patients, each with a minimum of 16 weeks of follow-up. Results Eighteen trials with 16,791 patients were included. Degludec was associated with a statistically significant reduction in risk for all confirmed hypoglycemia at the maintenance treatment period [estimated rate ratio (ERR) 0.81; 95% confidence interval (CI) 0.72‒0.92; P = 0.001], nocturnal confirmed hypoglycemia at the entire (ERR 0.71; 95% CI 0.63‒0.80; P Conclusions Insulin degludec appears to have better safety in reducing hypoglycemic events with similar efficacy compared with insulin glargine.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00592-018-1107-1

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 42 · Cited by 44

Metadata

Authors
Zhang, X.-W., Zhang, X.-L., Xu, B., & Kang, L.-N.
Affiliations
Nanjing Drum Tower Hospital (CN)
Venue
Acta Diabetologica
Published
2018-02-08
Volume
55
Issue
5
Pages
429-441
ISSN
  • 0940-5429 (ISSN-L)
  • 1432-5233
OpenAlex
W2789777142
Cited by
44
References
42
Citations by year
2025: 3 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 6 · 2019: 12 · 2018: 3
FWCI
1.12
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Acta Diabetologica (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81600312)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
Keywords
insulin degludec, insulin glargine, basal insulin analogues, type 1 diabetes, type 2 diabetes, hypoglycemia, nocturnal hypoglycemia, HbA1c, fasting blood glucose, adverse events, cardiovascular events, mortality
MeSH terms
Insulin Glargine, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Randomized Controlled Trials as Topic, Databases, Factual, Treatment Outcome, Insulin, Long-Acting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1007/s00592-018-1107-1
The paper
Zhang, X.-W., Zhang, X.-L., Xu, B., & Kang, L.-N. (2018). Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetologica. https://doi.org/10.1007/s00592-018-1107-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.